The September CVRG webinar will be held on Thursday, September 13, 2012 at 1:00 pm EDT. This month's talk will be given by Richard L. Verrier.
Dr. Verrier’s research program focuses on sudden cardiac death, which claims >325,000 lives annually in the United States alone. His studies emphasize elucidation of pathophysiologic mechanisms and development of novel approaches for identifying individuals at risk for this mode of demise, which occurs without prodromes in at least 30% of cases. He has a longstanding interest in electrophysiologic markers of arrhythmia risk and in use of T-wave alternans as a therapeutic target.
In this presentation, Richard will review the recent consensus guideline that was published in the Journal of the American College of Cardiology (2011;58:1309–24). The electrocardiographic bases of microvolt T-wave alternans (TWA) (i.e., a beat-to-beat alternation in the morphology and amplitude of the ST- segment or T-wave) will be briefly reviewed.
Click here for full details on this webinar.